Article highlights on alopecia areata from the 2024 American Academy of Dermatology Annual Meeting
Containing relevant Learning Zones, guidelines, trials and news.
While psychological stress is believed to be a major pathogenetic trigger in alopecia areata, infants and newborns also suffer from the disease, suggesting the possible presence of other environmental factors.
Unmet needs in alopecia areata, with a focus on the burden of disease, psychosocial impact on patients, developing management plans and potential emerging treatments.
Alopecia is associated with significant psychological burden. There is limited evidence on the use of psychological interventions in conditions of hair loss.
Alopecia areata is an autoimmune disease that results in non-scarring hair loss, and it is clinically characterised by small patches of baldness on the scalp and/or around the body.
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair loss involving the entire body.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle.
The aim of this review was to clarify the role of OS in AA pathogenesis and diagnosis, and to discuss potential treatment options.
Background: Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. Although there is an increased understanding of AA pathogenesis and progress in its treatments, the outcome of AA patients remains unfavorable, especially when they are progressing to the subtypes of alopecia totalis (AT) or alopecia universalis (AU).